Mucroporin-M1 inhibits hepatitis B virus replication by activating the mitogen-activated protein kinase (MAPK) pathway and down-regulating HNF4α in vitro and in vivo - Wikidata - awgldk - TriplyDB

Mucroporin-M1 inhibits hepatitis B virus replication by activating the mitogen-activated protein kinase (MAPK) pathway and down-regulating HNF4α in vitro and in vivo

Mucroporin-M1 inhibits hepatitis B virus replication by activating the mitogen-activated protein kinase (MAPK) pathway and down-regulating HNF4α in vitro and in vivo

http://www.wikidata.org/entity/Q36216315

about

Antiviral activity of animal venom peptides and related compounds Insights into Antimicrobial Peptides from Spiders and Scorpions Virocidal activity of Egyptian scorpion venoms against hepatitis C virus.Whole Transcriptome of the Venom Gland from Urodacus yaschenkoi Scorpion.In vitro analysis of the anticancer properties of scorpion venom in colorectal and breast cancer cell lines A Scorpion Defensin BmKDfsin4 Inhibits Hepatitis B Virus Replication in Vitro.Scorpion peptides: potential use for new drug development A Tat-conjugated Peptide Nucleic Acid Tat-PNA-DR Inhibits Hepatitis B Virus Replication In Vitro and In Vivo by Targeting LTR Direct Repeats of HBV RNA.Activity of Scorpion Venom-Derived Antifungal Peptides against Planktonic Cells of Candida spp. and Cryptococcus neoformans and Candida albicans Biofilms Peptides as the next generation of anti-infectives.Scorpion venoms as a potential source of novel cancer therapeutic compounds.Histidine-rich Modification of a Scorpion-derived Peptide Improves Bioavailability and Inhibitory Activity against HSV-1.Propolis Extract for Onychomycosis Topical Treatment: From Bench to Clinic.Intracellular interleukin-32γ mediates antiviral activity of cytokines against hepatitis B virus

P2860

Q28353903-C9E27DC7-A080-4814-8A31-1BCAB48BA023 Q28828405-4D8C8EFE-BF42-4E71-BAAE-CFE0B6CF5937 Q30389258-E46EA8AD-5BBE-40B1-A6B1-EC092D31784F Q35645121-056449EC-2FD1-4E5A-923E-E1438CED7769 Q36524603-FC92E410-7564-48F0-A43F-3E18052F7C14 Q36946907-D948AA9F-8839-4D48-A3AC-16E4FDD2F358 Q36971525-3E5C40B5-A996-4612-8FE6-CE042FA82093 Q37238749-EEEA4D6C-F6DD-4525-924E-1661339A6599 Q37421152-8540F2C8-99A0-474E-8AC6-625A6E0B16C5 Q38086871-D9AFC5BB-0950-4457-8D4F-D5739192CE02 Q38193765-6743EC52-C253-4429-8327-44C42569EE56 Q47171976-C5358A8B-74D1-48AC-9930-18C9B5E32B3D Q55408742-D0E52929-CBCE-4E6E-9D40-E994C5493561 Q58774481-F4B3C6FB-CDB4-45A5-8860-D755AE5BDAAB

P2860

Mucroporin-M1 inhibits hepatitis B virus replication by activating the mitogen-activated protein kinase (MAPK) pathway and down-regulating HNF4α in vitro and in vivo

http://www.wikidata.org/entity/Q36216315

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Mucroporin-M1 inhibits hepatit ...... ing HNF4α in vitro and in vivo

@ast

Mucroporin-M1 inhibits hepatit ...... ing HNF4α in vitro and in vivo

@en

type

label

Mucroporin-M1 inhibits hepatit ...... ing HNF4α in vitro and in vivo

@ast

Mucroporin-M1 inhibits hepatit ...... ing HNF4α in vitro and in vivo

@en

prefLabel

Mucroporin-M1 inhibits hepatit ...... ing HNF4α in vitro and in vivo

@ast

Mucroporin-M1 inhibits hepatit ...... ing HNF4α in vitro and in vivo

@en

P1433

Q36216315-606D90DF-3728-4926-8520-988791DB858A

P1476

Q36216315-51F6DA58-55DA-4274-A385-234793E18DF1

P2093

Q36216315-29E40DCA-94D6-48DF-B87A-9EC333CD1B15

Q36216315-3CB13A57-82C3-4FED-B061-C7CD69735E85

Q36216315-4D5637BE-6A58-432F-8EEE-33FC4F4E56EE

Q36216315-8C8EC788-900A-47D8-B2A4-9FECB85EC869

Q36216315-97231847-C57F-4252-AA35-C0A92F95DBE5

Q36216315-DE68B7F2-B4A9-4BDF-956B-C3D7B5843777

Q36216315-E805D2E5-D69A-444A-A10A-0156F025D6B0

P2860

Q36216315-026DA049-0904-46D3-A61B-7AF5E4E6AC9A

Q36216315-0C5E0136-27E0-40F4-B4CF-C2C8FE23F4B1

Q36216315-0D919DE5-FD08-4055-9C12-73B2AB4C67BF

Q36216315-1AC71B02-EBD5-4ED7-B608-8C8345B213BB

Q36216315-1EEC575E-483A-4B32-A692-4968B66A1A5E

Q36216315-24A6EBC1-F1F6-4ACD-A3D5-A3557DAE65A5

Q36216315-24CF3963-3BF2-4D20-8787-5FB616516335

Q36216315-32638E19-9494-4081-BB85-2B24D745EAA5

Q36216315-3497CB1D-82E5-4A1A-ADE6-80B21531B565

Q36216315-48FFB032-D723-4FE7-B728-FDA43B96A9D6

P304

Q36216315-74A8AB23-8ABD-48B9-B1EF-E1CE6DB4AF6F

P31

Q36216315-455C950A-F335-4D44-8EA3-9ACA555CE754

P356

Q36216315-40506004-4773-4D1B-ABFF-C9740CEF5EB8

P407

Q36216315-92F98DDE-381B-4027-AF98-9555F0B4EAEB

P433

Q36216315-11AF2AC0-7712-4C28-A0AB-10B24AD2998B

P478

Q36216315-E7EDE345-4A7A-4257-B979-03EA12A71B9C

P50

Q36216315-29DD37C5-578B-424F-B01D-B47078C3B857

P577

Q36216315-3E65625E-D81C-4BE8-99F1-32D1A7F3ED8F

P698

Q36216315-0C972C44-DA09-40E2-BB7B-8B383CD18E12

P932

Q36216315-20A3017E-D7ED-46D9-8A9D-56DC2F534527

P356

JBC.M112.370312

P1433

Journal of Biological Chemistry

P1476

Mucroporin-M1 inhibits hepatit ...... ing HNF4α in vitro and in vivo

@en

P2093

Kanghong Hu

http://www.w3.org/2001/XMLSchema#string

Wei Hong

http://www.w3.org/2001/XMLSchema#string

Wenxin Li

http://www.w3.org/2001/XMLSchema#string

Xiaohui Tian

http://www.w3.org/2001/XMLSchema#string

Yingliang Wu

http://www.w3.org/2001/XMLSchema#string

Zhengyang Zeng

http://www.w3.org/2001/XMLSchema#string

Zhijian Cao

http://www.w3.org/2001/XMLSchema#string

P2860

Antimicrobial peptides from amphibian skin potently inhibit human immunodeficiency virus infection and transfer of virus from dendritic cells to T cells.

Distinct modes of regulation of transcription of hepatitis B virus by the nuclear receptors HNF4alpha and COUP-TF1

Human alpha-defensins neutralize anthrax lethal toxin and protect against its fatal consequences

Crystal structure of the HNF4 alpha ligand binding domain in complex with endogenous fatty acid ligand

The human beta-defensins (-1, -2, -3, -4) and cathelicidin LL-37 induce IL-18 secretion through p38 and ERK MAPK activation in primary human keratinocytes

Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis

Identification of multiple transcription factors, HLF, FTF, and E4BP4, controlling hepatitis B virus enhancer II.

Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein.

A new natural α-helical peptide from the venom of the scorpion Heterometrus petersii kills HCV.

Expression profile analysis of the inflammatory response regulated by hepatocyte nuclear factor 4α

P304

30181-30190

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M112.370312

http://www.w3.org/2001/XMLSchema#string

P407

P433

36

http://www.w3.org/2001/XMLSchema#string

P478

287

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-07-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22791717

http://www.w3.org/2001/XMLSchema#string

P932

3436272

http://www.w3.org/2001/XMLSchema#string